Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
- 30 March 2007
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 120 (1-2), 18-26
- https://doi.org/10.1016/j.jconrel.2007.03.012
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Essential properties of drug-targeting delivery systemsDrug Discovery Today, 2005
- Targeted for drug deliveryMaterials Today, 2005
- Drug-conjugated monoclonal antibodies for the treatment of cancerCurrent Opinion in Pharmacology, 2005
- Recent advances in tumor-targeting anticancer drug conjugatesBioorganic & Medicinal Chemistry, 2005
- Ligand-targeted liposomal anticancer drugsProgress in Lipid Research, 2003
- Monoclonal antibody drug immunoconjugates for targeted treatment of cancerCancer Immunology, Immunotherapy, 2003
- Targeted drug conjugates: principles and progressAdvanced Drug Delivery Reviews, 2001
- Monoclonal antibodies and therapy of human cancersBiotechnology Advances, 2000
- Monoclonal antibody drug conjugates in the treatment of cancerCurrent Opinion in Immunology, 1999
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975